TABLE 4.
Suppression of cytokine synthesis
| Organism | Process inhibiteda | Active component | Reference |
|---|---|---|---|
| Actinomyces actinomycetemcomitans | Release of IL-2, IL-4, IL-5, and IFN-γ from ConA-stimulated murine CD4+ cells | 14-kDa protein | 34 |
| Escherichia coli | Expression of mRNA for IL-2, IL-4, IL-5, and IFN-γ in PMA-stimulated PBMCs | 8-kDa protein | 33 |
| Yersinia enterocolitica | TNF-α release from LPS-stimulated murine macrophages | YopB | 3 |
| Brucella suis | TNF-α release from E. coli-infected macrophages | 45- to 50-kDa protein | 6 |
| Vibrio cholerae | TNF-α release from rat peritoneal mast cells | Cholera toxin | 35 |
| Bacillus anthracis | TNF-α secretion by LPS-stimulated human monocytes | Anthrax edema toxin | 29 |
| Pseudomonas aeruginosa | Synthesis of IL-1α, IL-1β, TNF-α, and IFN-γ by PHA-stimulated human monocytes | ADP-ribosylating toxin | 48 |
| TNF-α and IL-12 release from LPS-stimulated human monocytes | 3-Oxododecanoyl-l-homoserine lactone | 58 | |
| Salmonella typhimurium | Synthesis of IL-2 by murine T lymphocytes | Protein | 38 |
ConA, concanavalin A; PBMCs, peripheral blood mononuclear cells; PHA, phytohemagglutinin.